Monoclonal antibody therapy for breast cancer: herceptin.

Cancer chemotherapy and biological response modifiers

Volumn 21, Issue , 2003, Pages 223-233

  Finn, Richard S ^a   Slamon, Dennis J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB;

ADJUVANT CHEMOTHERAPY; BREAST TUMOR; CLINICAL TRIAL; FEMALE; GENETICS; HUMAN; REVIEW;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; FEMALE; HUMANS; RECEPTOR, ERBB-2;

MLCS; MLOWN;

EID: 4444350367     PISSN: 09214410     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0921-4410(03)21010-3     Document Type: Review

References (45)